UK’s MHRA Unveils Plans for AI as a Medical Device

The United Kingdom’s medicines and medical devices regulator has unveiled its approach to AI in a report presented to the UK government, urging transparency, inclusivity and aligning with partners globally among its key published principles.

The Medicines and Healthcare products Regulatory Agency (MHRA) policy paper released last week makes clear the regulator’s intent to embrace AI as a device for medical purposes, while acknowledging oversight would take into account “the risks of these products without stifling the potential they have to transform healthcare.”

The paper also emphasizes that a government strategy on AI should be based on safety, security and be in tandem with international partners to make timely decisions that best protect patient health and safety.

View the MHRA policy paper here.

To read the whole story, click here.

Related Topics